Table 5: Extract from Ivermectin treatment for COVID-19: real time meta-analysis of 64 studies.
Parameter |
Number of studies |
Relative Risk (95%CI) |
Total number of patients |
Percentage improvement |
Mortality |
26 |
0.44 (0.32-0.60) |
36,163 |
56% |
Recovery overall |
21 |
0.48 (0.35-0.67) |
3932 |
52% |
Recovery early treatment |
11 |
0.34 (0.19-0.63) |
2048 |
66% |
Recovery late treatment |
10 |
0.67 (0.53-0.86) |
1878 |
33% |
Viral clearance |
21 |
0.41 (0.29-0.57) |
2,296 |
59% |
Prophylaxis |
14 |
0.14 (0.08-0.25) |
13,052 |
86% |
Extracted from https://ivmmeta.com [30] October 29th 2021. This meta-analysis includes Babalola, et al. [4].